An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-06-01
著者
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
MEGURO KUNIAKI
National Sendai Hospital
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
ANDO Kiyoshi
Tokai University
-
Okamoto Shin-ichiro
国立がんセンター中央病院 血液内科
-
USUKI Kensuke
NTT Kanto Medical Center
-
MIYAMURA Koichi
Japanese Red Cross Nagoya First Hospital
-
Meguro Kuniaki
東北大学 医学部分子診断学
-
SHIRASUGI Yukari
Tokai University Hospital
-
HASHINO Satoshi
Hokkaido University Hospital
-
IWATO Koji
Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
-
Iwato Koji
Department Of Blood Transfusion Hiroshima Red Cross Hospital And Atomic-bomb Survivors Hospital
-
Usuki Kensuke
Division Of Hematology Ntt Kanto Medical Center
-
Miyamura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Miyamoto Ken-ichi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Miyamura Koichi
東北大学 医学系研究科血液･免疫病学分野
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
Kurokawa Mineo
Department Of Hematology And Oncology University Of Tokyo
-
Mori Shinichiro
Department Of Accelerator And Medical Physics Research Center For Particle Therapy National Institut
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Yonemura Yuji
Department Of Hematology Kumamoto University School Of Medicine
-
Tomiyama Y
Department Of Hematology And Oncology Graduate School Of Medicine Osaka University
-
Ninomiya Haruhiko
Division Of Hematology Institute Of Clinical Medicine University Of Tsukuba
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Miyazaki Koji
Department Of Biological Functions And Engineering Kyushu Institute Of Technology
-
Yonemura Yuji
Department Of Transfusion Medicine And Cell Therapy Kumamoto University Hospital
-
Wei Helen
Biostatistics Amgen Inc.
-
Shirasugi Yukari
Department Of Hematology And Oncology Tokai University Hospital
-
Lizambri Richard
Clinical Development Amgen Inc.
-
Mori Shinichiro
Department Of Hematology And Oncology Kansai Medical University Hirakata Hospital
-
Tomiyama Yoshiaki
Department Of Blood Transfusion Osaka University Hospital
-
Kurokawa Mineo
Department Of Hematology And Oncology The University Of Tokyo Hospital
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Hashino Satoshi
Department Of Gastroenterology And Hematology Hokkaido University Hospital
-
Miyazaki Koji
Department Of Hematology Kitasato University Hospital
-
Kirito Keita
Department Of Hematology And Oncology University Of Yamanashi Hospital
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine The University Of Tokyo
-
WEI Helen
Amgen Inc.
-
LIZAMBRI Richard
Amgen Inc.
-
MIYAZAKI Koji
Department of Applied Chemistry, Tokyo Metropolitan University
-
Kurokawa Mineo
Department of Hematology & Oncology, The University of Tokyo
-
KUROKAWA Mineo
Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo
-
OKAMOTO Shin-ichiro
Keio University Hospital
関連論文
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Long-term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
- Clinical impact of a newly developed capsule endoscope : usefulness of a real-time image viewer for gastric transit abnormality
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia
- Mechanisms of retinoid resistance in a myeloid cell line, YM711,transfected with PML/RARα cDNA : possible involvement of redox potential
- Gelatinous Degeneration in a Recipient of Allogeneic Bone Marrow Transplantation
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Changes in Microbial Flora in Neutropenic Patients With Hematological Disorders After the Hanshin-Awaji Earthquake
- Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation
- Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
- Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
- Detection of donor-type alveolar macrophages in transplantation with highly purified CD34^+ bone marrow cells
- Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation
- Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient
- Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients : an association with bioavailability of oral solution itraconazole
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
- Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
- Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
- A Flare-Up of Chronic Graft-versus-Host Disease of the Liver That Mimics Acute Hepatitis in a Recipient of an Allogeneic Peripheral Blood Stem Cell Transplant
- Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
- Successful Treatment of Extramedullary Blast Crisis of Chronic Myelogenous Leukemia with Imatinib Mesylate (STI571)
- Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
- Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
- Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation
- Esophageal varices and portal hypertensive gastropathy associated with hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation
- Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- Multilineage Involvement of Light Microscopic Myeloperoxidase-Negative Acute Leukemia
- Clostridium subterminale Septicemia in a Recipient of Allogeneic Cord Blood Transplantation
- Granisetron plus Dexamethasone versus Granisetron Alone in the Prevention of Vomiting Induced by Conditioning for Stem Cell Transplantation : A Prospective Randomized Study
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia
- An Adult Patient With Hypersensitivity to Mosquito Bites Developing Mantle Cell Lymphoma
- Extramedullary Blast Crisis Derived from 2 Different Clones in the Central Nervous System and Neck during Complete Cytogenetic Remission of Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
- Follicular Lymphoma in Osaka, Japan : Histological Features and Chronological Change
- A Case of Hypoplastic Chronic Myelogenous Leukemia Initiating With Pancytopenia
- Ex Vivo Expansion of Human Cord Blood Stem Cells and Its Application to Gene Therapy
- A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker
- Possible involvement of the TGF-β1 signal in the development of peritoneal sclerosis as one of the major complications in continuous ambulatory peritoneal dialysis
- Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation
- Serum KL-6 Levels in Patients With Pulmonary Complications After Allogeneic Bone Marrow Transplantation
- Relation between Chromosomal Aberrations and Radiation Dose during the Process of TBI
- Ikk-i, a novel Lipopolysaccharide-inducible kinase that is realted to lκB Kinases
- Coping strategy when patients with quiescent Crohn's disease recognize that their conditions are worsening
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Eosinophilic Colitis in a Patient with Acute Myeloid Leukemia after Allogeneic Bone Marrow Transplantation
- Clostridium subterminale Septicemia in a Recipient of Allogeneic Cord Blood Transplantation
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis
- Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients
- Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)